Company
Pinetree Therapeutics
| Industry | biotechnology company advancing next-generation targeted protein degraders (TPD) to combat drug resistance in oncology and beyond |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Pinetree Therapeutics | Series A Funding | 2024-07-30 |